Bluefin Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Bluefin Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-10,604	Closed	-$3.44M	–	653
2019 Q4	$3.44M	Buy	10,604 +7,222	+214%	+$2.19M	0.23%	105
2019 Q3	$985K	Buy	+3,382	New	+$968K	0.14%	112
2015 Q4	–	Sell	-2,600	Closed	-$318K	–	768
2015 Q3	$318K	Buy	+2,600	New	+$339K	0.02%	303
2014 Q3	–	Sell	-40,037	Closed	-$4.7M	–	1057
2014 Q2	$4.7M	Sell	40,037 -3,763	-9%	-$443K	0.2%	86
2014 Q1	$5.3M	Buy	+43,800	New	+$5.21M	0.34%	52

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bluefin Capital Management's TMO Position: Q1 2020 in Review

Bluefin Capital Management sold out of Thermo Fisher Scientific (TMO) in Q1 2020, closing a stake of 10,604 shares — an estimated $3.44M sold.

Bluefin Capital Management first reported a position in TMO in Q1 2014 and held it in 5 quarters. The position peaked at $5.3M in Q1 2014. 1,674 funds tracked by Wall St. Rank hold TMO as of Q1 2020.

Bluefin Capital Management reported no remaining Thermo Fisher Scientific position as of Q1 2020 after selling out during the quarter.
Bluefin Capital Management sold 10,604 Thermo Fisher Scientific shares in Q1 2020, an estimated $3.44M.
Bluefin Capital Management first reported a position in Thermo Fisher Scientific in Q1 2014 and held it in 5 quarters.
Bluefin Capital Management's Thermo Fisher Scientific position peaked at $5.3M in Q1 2014.
1,674 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2020.

Based on Bluefin Capital Management's 13F filing for Q1 2020, filed 15 May 2020.